End of Life Choice Bill - Amendment paper No 215
End of Life Choice Bill - Amendment paper No 215
Checking for alerts... Loading...
End of Life Choice Bill - Amendment paper No 215
No 215
House of Representatives
Supplementary Order Paper
Tuesday, 10 September 2019
End of Life Choice Bill
Proposed amendment
Simon O’Connor, in Committee, to move the following amendment:
New clause 21C
After clause 21B (page 16, after line 4), insert:
21C PHARMAC report
(1)
PHARMAC must publish a report annually that includes information on—
(a)
the quantities of medications funded for use under this Act in the relevant year; and
(b)
the total cost of the medications identified in paragraph (a); and
(c)
other medications that would have been funded by PHARMAC if not for the funding of medication for the purposes of this Act.
(2)
In this section, PHARMAC means the Pharmaceutical Management Agency.
Explanatory note
This Supplementary Order Paper amends the End of Life Choice Bill. It establishes a reporting requirement for PHARMAC to publish an annual report on the funding of medication for the purposes of the Bill.
"Related Legislation
"Related Legislation
"Related Legislation
Versions
End of Life Choice Bill - Amendment paper No 215
RSS feed link copied, you can now paste this link into your feed reader.